Ovasitol vs Pink Stork: Which Inositol Fits Better?

Ovasitol original and Pink Stork 3.6:1 have different inositol proportions, not just different formats. Pink Stork’s public serving information also conflicts. Confirm the supplied capsule label before treating it as an alternative to the powder or comparing daily costs.

The practical difference

Ovasitol

Ovasitol offers the two inositols as an unflavoured powder, with a scoop or individual packets. It suits a comparison based on mixing, portability and pack cost rather than capsule count.

The 90-day canister supplies 180 servings when used according to the manufacturer’s twice-daily instructions. One scoop is a serving, not the full labelled day. At the checked one-time manufacturer price of $86.68, that routine costs about $0.96 a day before any delivery or tax differences. Packet prices are separate and are not included in that calculation.

Powder avoids swallowing capsules but adds a measuring and mixing step. Packets remove measuring and can be easier to carry, but the packet pack must be priced separately. The manufacturer lists NSF certification; this is a quality-documentation difference, not proof that Ovasitol produces better clinical results.

Read the full Ovasitol label assessment.

Pink Stork

Pink Stork uses a higher-D-chiro proportion than a 40:1 product. The manufacturer markets it as 3.6:1, so it should not be treated as a like-for-like replacement based only on the words “myo and D-chiro”.

The current manufacturer gallery shows 1,100 mg myo-inositol and 300 mg D-chiro-inositol per two-capsule serving, while its FAQ says three capsules daily. These are conflicting current materials, not simply an old-versus-new distinction. The pictured 60-capsule bottle gives 30 days at two daily or 20 at three. Confirm the supplied label and directions before comparing daily amounts or cost.

A different ratio is a formulation difference, not proof of better ovarian or fertility outcomes. Current international guidance does not endorse a universal inositol ratio. Pink Stork’s own guidance says to use the product until a positive pregnancy test; check the bottle and your clinician’s plan rather than assuming continued use during pregnancy.

Read the full Pink Stork label assessment.

A different proportion cannot be matched by capsule count

Increasing or decreasing the number of servings changes both inositol amounts together; it does not change their ratio. You therefore cannot make these formulas equivalent by matching only the myo-inositol amount. This comparison does not recommend a conversion or DIY mixture.

The manufacturer page also names ingredients in its ingredient section that do not match the quantitative panel documented in our Pink Stork review. Do not combine those sections into an assumed formula. Ask for the complete label of the bottle that will actually be supplied.

Compare the cost of the labelled routine

Pink Stork’s US manufacturer page showed a $46 one-time purchase on October 12, 2026. For the pictured 60-capsule bottle, two daily would mean 30 days and about $1.53 per day; three daily would mean 20 days and $2.30 per day. These are conditional calculations, not directions. Subscription discounts, tax and delivery are excluded.

Do not select the cheaper scenario as the correct instruction. First resolve the supplied label. Ovasitol’s previously checked price and routine are described above, but a daily-price comparison does not compare equal inositol amounts or equivalent formulations. Neither price establishes a better fertility outcome.

What the evidence can tell us

Studies of myo-inositol, D-chiro-inositol or their combination do not establish that either named brand works better. The 2023 international PCOS guideline notes possible metabolic benefits but limited clinical benefits, and cannot recommend a specific type, dose or combination. For PCOS-related infertility, it considers inositol experimental because the benefits and risks remain uncertain.

Read the 2023 international PCOS guideline, sections 4.7 and 5.8.

The guideline-informing systematic review included 30 trials with varied formulations and comparisons and concluded that the overall evidence was limited and inconclusive. The small seven-ratio trial enrolled only eight participants per group; it cannot establish a universal optimal ratio or a superior commercial product.

Fitz et al. (2024): guideline-informing systematic review.

Nordio et al. (2019): small seven-ratio comparison.

Which label fits your requirements?

Ovasitol

Shortlist the canister if you prefer mixing powder and its labelled twice-daily routine fits the plan agreed with your clinician. Compare capsules if portability without a drink is more useful. Check the exact Ovasitol version: the original product, packets and other branded variants are not interchangeable packs.

Pink Stork

Consider this only as a deliberate comparison of a different formulation, after confirming the complete label and pack. If you are seeking a 40:1 product, use that specific comparison instead of selecting by brand familiarity.

Before ordering

Match the current retailer bottle to the manufacturer information: exact product name, capsule or powder version, active amounts, added nutrients and pack count. If you take medication, are pregnant or are trying to conceive, bring that exact label to the clinician or pharmacist who knows your care. A product comparison is not an instruction to start, stop or increase a supplement.

Product information and assessment scope

Ovasitol: manufacturer product information checked for this comparison.

Pink Stork: manufacturer product information checked for this comparison.

This comparison uses public product information and published research. We have not independently tested these bottles or measured comparative clinical outcomes. Product facts, dated prices and the scope of scientific source checks are reported separately.

See the Pink Stork review for the current label image, ingredient discrepancy and conditional cost calculations.